Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Aadi Bioscience
Aadi Bioscience
(AADI)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Fyarro
Sirolimus
2021-11-22
2029-2040
Angiofibroma
,
Graft rejection
,
Kidney transplantation
,
Tuberous sclerosis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Sirolimus
pulmonary hypertension
,
drug resistant epilepsy
,
multiple myeloma
,
colorectal neoplasms
,
sarcoma
,
perivascular epithelioid cell neoplasms
,
neoplasms
,
neuroendocrine tumors
,
glioblastoma
,
leigh disease
,
neoplasm metastasis
,
renal cell carcinoma
,
urologic neoplasms
,
non-small-cell lung carcinoma
,
hepatocellular carcinoma
,
hodgkin disease
,
melanoma
,
liver neoplasms
,
squamous cell carcinoma
,
squamous cell neoplasms
,
chordoma
,
ewing sarcoma
Albumin
pulmonary hypertension
,
neoplasms
,
glioblastoma
,
colorectal neoplasms
,
sarcoma
,
leigh disease
,
neoplasm metastasis
,
neuroendocrine tumors
Marizomib
glioblastoma
Calcium dobesilate
multiple myeloma
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use